The genetic test maps 150+ personalized insights that extend beyond simple weight loss prediction to include metabolic resilience, appetite regulation patterns, and potential response to alternative compounds like tirzepatide
Sleep Study : If sleep apnea is suspected, your doctor may recommend a sleep study (polysomnography) to monitor your breathing patterns, heart rate, and oxygen levels during sleep
other trials differ) A history of unsuccessful weight loss through diet and lifestyle changes Common Reasons People Are Excluded Personal or family history of medullary thyroid carcinoma (MTC) or MEN syndrome type 2 Prior pancreatitis A type 2 diabetes diagnosis (for the obesity-only arm) Body weight change greater than 5 kg in the 90 days before screening Use of any weight-loss medication within the prior 90 days Recent cardiovascular events, which are handled differently in the cardiovascular trials If you have type 2 diabetes: Lilly has tested retatrutide in diabetes through a separate study program, but the obesity-focused TRIUMPH-1 trial excluded diabetes
Specialized clinics and some forward-thinking physicians are actively treating EDS patients with them, and publishing case reports, patient series, and even starting trials to accumulate evidence